PC97
category
Intentional self-harm by exposure to or harmful effects of antiepileptics or antiparkinsonism drugs
Also indexed as
Intentional overdose of L-DOPAIntentional overdose of amantadineIntentional overdose of antiepileptics or antiparkinsonism drugsIntentional overdose of antiepileptics or antiparkinsonism drugs, Hydantoin derivativesIntentional overdose of antiparkinsonism drugs or other central muscle-tone depressants, not elsewhere classifiedIntentional overdose of antispasticity drugsIntentional overdose of deoxybarbituratesIntentional overdose of iminostilbenesIntentional overdose of mixed antiepileptics, not elsewhere classifiedIntentional overdose of oxazolidinedionesIntentional overdose of succinimidesIntentional overdose of valproic acidIntentional self-harm by exposure to or harmful effects of L-DOPAIntentional self-harm by exposure to or harmful effects of amantadineIntentional self-harm by exposure to or harmful effects of antiepileptics or antiparkinsonism drugsIntentional self-harm by exposure to or harmful effects of antiepileptics or antiparkinsonism drugs, Hydantoin derivativesIntentional self-harm by exposure to or harmful effects of antiparkinsonism drugs or other central muscle-tone depressants, not elsewhere classifiedIntentional self-harm by exposure to or harmful effects of antispasticity drugsIntentional self-harm by exposure to or harmful effects of deoxybarbituratesIntentional self-harm by exposure to or harmful effects of iminostilbenesIntentional self-harm by exposure to or harmful effects of mixed antiepileptics, not elsewhere classifiedIntentional self-harm by exposure to or harmful effects of oxazolidinedionesIntentional self-harm by exposure to or harmful effects of succinimidesIntentional self-harm by exposure to or harmful effects of valproic acidIntentional self-poisoning by exposure to or harmful effects of L-DOPAIntentional self-poisoning by exposure to or harmful effects of amantadineIntentional self-poisoning by exposure to or harmful effects of antiepileptics or antiparkinsonism drugsIntentional self-poisoning by exposure to or harmful effects of antiepileptics or antiparkinsonism drugs, Hydantoin derivativesIntentional self-poisoning by exposure to or harmful effects of antiparkinsonism drugs or other central muscle-tone depressants, not elsewhere classifiedIntentional self-poisoning by exposure to or harmful effects of antispasticity drugsIntentional self-poisoning by exposure to or harmful effects of deoxybarbituratesIntentional self-poisoning by exposure to or harmful effects of iminostilbenesIntentional self-poisoning by exposure to or harmful effects of mixed antiepileptics, not elsewhere classifiedIntentional self-poisoning by exposure to or harmful effects of oxazolidinedionesIntentional self-poisoning by exposure to or harmful effects of succinimidesIntentional self-poisoning by exposure to or harmful effects of valproic acid
Nearby in Intentional self-harm by exposure to or harmful effects of drugs, medicaments or biological substances
PC90Intentional self-harm by exposure to or harmful effects of opioids or related analgesicsPC91Intentional self-harm by exposure to or harmful effects of sedative hypnotic drugs or other CNS depressantsPC92Intentional self-harm by exposure to or harmful effects of psychostimulantsPC93Intentional self-harm by exposure to or harmful effects of cannabinoids or hallucinogensPC94Intentional self-harm by exposure to or harmful effects of analgesics, antipyretics or nonsteroidal anti-inflammatory drugsPC95Intentional self-harm by exposure to or harmful effects of antidepressantsPC96Intentional self-harm by exposure to or harmful effects of antipsychoticsPC98Intentional self-harm by exposure to other or unspecified drug, medicament or biological substance